PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 123 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $202,704,000 | -29.5% | 53,343 | -5.5% | 0.00% | – |
| Q4 2019 | $287,392,000 | -5.0% | 56,462 | -5.7% | 0.00% | – |
| Q3 2019 | $302,668,000 | +4.3% | 59,875 | +27.4% | 0.00% | – |
| Q2 2019 | $290,058,000 | +63.2% | 47,011 | +22.7% | 0.00% | – |
| Q1 2019 | $177,745,000 | +10.5% | 38,307 | 0.0% | 0.00% | – |
| Q4 2018 | $160,889,000 | -33.0% | 38,307 | 0.0% | 0.00% | – |
| Q3 2018 | $240,185,000 | -22.0% | 38,307 | 0.0% | 0.00% | – |
| Q2 2018 | $307,987,000 | -13.7% | 38,307 | -20.0% | 0.00% | – |
| Q1 2018 | $356,999,000 | +51.7% | 47,855 | +21.0% | 0.00% | – |
| Q4 2017 | $235,317,000 | -19.2% | 39,549 | 0.0% | 0.00% | – |
| Q3 2017 | $291,080,000 | +10.7% | 39,549 | +2.1% | 0.00% | – |
| Q2 2017 | $262,936,000 | -28.1% | 38,724 | 0.0% | 0.00% | – |
| Q1 2017 | $365,554,000 | +154142.2% | 38,724 | +41.2% | 0.00% | – |
| Q4 2016 | $237,000 | -1.2% | 27,424 | -27.6% | 0.00% | – |
| Q3 2016 | $240,000 | +66.7% | 37,862 | +11.0% | 0.00% | – |
| Q2 2016 | $144,000 | -3.4% | 34,100 | 0.0% | 0.00% | – |
| Q1 2016 | $149,000 | -28.7% | 34,100 | 0.0% | 0.00% | – |
| Q4 2015 | $209,000 | -0.9% | 34,100 | -7.6% | 0.00% | – |
| Q3 2015 | $211,000 | -16.9% | 36,900 | +8.2% | 0.00% | – |
| Q2 2015 | $254,000 | – | 34,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |